中国生物工程杂志

Thanks to the advantage of the characteristics of biotech drugs itself, biotech drugs is developing quickly. In the broader market, sales from biotechnology products are expected to account for 27% of the world's pharmaceutical sales by 2020, versus the current share of 22% in 2013. Roche is expected to remain the biggest player in the biotechnology space with sales increasing by $14.5bn to $43.5bn in 2020, representing an annual growth of 6% per annum. In support of the government, China have formed industrial clusters based on the Chinese medicine group as the leading. While total market of Chinese biotechnology drugs accounted for the global market is only 2%, but future is larger. At present China has formed industrial clusters,the biggest player of which is Sinopharm. With the increased demand for disease treatment, Biotech drugs has huge developing potential, the market will further expand.